KELCEY NELLIS: Open Payments
NPI 1497417992 · LATHAM, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,706 in 116 payments from 16 companies in 2025. Trend: 2023 $1,072 · 2024 $2,597 · 2025 $2,706
Food & beverage: $2,305Consulting: $396Education: $5
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 8 | $688 |
| ABBVIE INC. | 47 | $621 |
| Janssen Biotech, Inc. | 12 | $405 |
| Novartis Pharmaceuticals Corporation | 17 | $267 |
| UCB, Inc. | 5 | $148 |
| GENZYME CORPORATION | 4 | $121 |
| E.R. Squibb & Sons, L.L.C. | 4 | $78 |
| Galderma Laboratories, L.P. | 4 | $74 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $58 |
| Incyte Corporation | 2 | $49 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, RINVOQ, COSENTYX, Bimzelx, Sotyktu, Rhapsido.
Industry payments across NY — which companies pay providers there.
